Company intelligence
ipill
Next Gen MAT/MOUD Treatment Device - Improving Safety and Access to MAT/MOUD at Home
About ipill
iPill Adherence Tech Services is a U.S.–based medication-adherence technology company transforming how controlled and high-risk medications are prescribed, dispensed, and monitored. Our patented, FDA-cleared iPill® Smart Dispenser securely releases medication only to the intended patient at the prescribed time—protecting against diversion, overdose, and non-adherence. Through our Adhere360™ platform, we deliver a turnkey subscription model that connects providers, pharmacies, and payers in one compliance-driven ecosystem. We support Medication-Assisted Treatment (MAT/MOUD), pain management, corrections, and behavioral health organizations by integrating remote monitoring, analytics, and refill logistics into a seamless patient-care experience. Our mission is simple: to make every dose safe, accountable, and data-driven.
Verified activity
Signals from ipill
3 published signals
Research & Knowledge
ipill reports that 75% of hypertension patients receive medication and 17% of people with opioid use disorder do.
Reported by William Pedranti
Presence & Recognition
ipill is filming a new episode of The Saving Dose podcast behind the scenes.
Reported by William Pedranti
Presence & Recognition
ipill released the latest episode of The Saving Dose featuring Sandy Eulitt's story about chronic pain and opioid use disorder.
Reported by William Pedranti